Skip to main content
NCBI home page
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2001 Dec;18(12):644–649. doi: 10.1023/A:1013111200251

Reduced Developmental Potential in Oocytes from Women with Endometriosis

Sophie Naffah Norenstedt 1, Christina Linderoth-Nagy 1, Annica Bergendal 1, Peter Sjöblom 1,2, Agneta Bergqvist 1
PMCID: PMC3455250  PMID: 11808845

Abstract

Purpose: To study retrospectively the outcome of intracytoplasmatic sperm injection (ICSI) in women with endometriosis compared with women with no known female infertility factor.

Methods: All couples treated with ICSI because of male infertility plus verified endometriosis (n = 26) and all couples treated with ICSI because of male infertility only (n = 125) during the period January 1995 to June 1999 were included. Data were collected from patient files and ICSI protocols.

Results: The time to complete down regulation was significantly longer (p = 0.0108), the dose of FSH significantly higher (0.0247), the day for oocyte pickup significantly later (p = 0.0091), and the cleavage rate of oocytes significantly lower (p = 0.0011) in women with endometriosis compared with controls. There was no significant difference in implantation rate or pregnancy rate between the groups.

Conclusions: Women with endometriosis presented significantly reduced follicular response and oocyte cleavage rate, two mechanisms that might be related to a disturbed oogenesis.

Keywords: cleavage rate, endometriosis, fertilization rate, ICSI, implantation rate, infertility, pregnancy outcome

Full Text

The Full Text of this article is available as a PDF (60.9 KB).

REFERENCES

  • 1.Haney AF. Endometriosis-associated infertility. Reprod Med Rev. 1997;6:145–161. [Google Scholar]
  • 2.Wu M-Y, Chao K-H, Chen S-U, Chen H-F, Yang Y-S, Huang S-C, Ho H-N. The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol. 1996;35:510–516. doi: 10.1111/j.1600-0897.1996.tb00050.x. [DOI] [PubMed] [Google Scholar]
  • 3.Hill JA. Immunology and endometriosis. Obstet Gynecol Clin North Am. 1997;24:291–306. doi: 10.1016/s0889-8545(05)70305-3. [DOI] [PubMed] [Google Scholar]
  • 4.Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: The role of peritoneal fluid. Hum Reprod. 1998;4:741–751. doi: 10.1093/humupd/4.5.741. [DOI] [PubMed] [Google Scholar]
  • 5.Bergqvist A. Current drug therapy recommendations for the treatment of endometriosis. Drugs. 1999;58:39–50. doi: 10.2165/00003495-199958010-00004. [DOI] [PubMed] [Google Scholar]
  • 6.Marcoux S, Maheux R, Bérubé S. The Canadian Collaborative Group on Endometriosis: Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med. 1997;337:217–222. doi: 10.1056/NEJM199707243370401. [DOI] [PubMed] [Google Scholar]
  • 7.Mahmood TA, Arumugam K, Templeton AA. Oocyte and follicular fluid characteristics in women with mild endometriosis. Br J Obstet Gynaecol. 1991;98:573–577. doi: 10.1111/j.1471-0528.1991.tb10373.x. [DOI] [PubMed] [Google Scholar]
  • 8.Geber S, Paraschos T, Atkinson G, Margara R, Winston RML. Results of IVF in patients with endometriosis: The severity of the disease does not affect outcome, or the incidence of miscarriage. Hum Reprod. 1995;10:1507–1511. doi: 10.1093/humrep/10.6.1507. [DOI] [PubMed] [Google Scholar]
  • 9.Olivennes F, Feldberg D, Liu H-C, Cohen J, Moy F, Rosenwaks Z. Endometriosis: A stage by stage analysis-The role of in vitro fertilization. Fertil Steril. 1995;64:392–398. doi: 10.1016/s0015-0282(16)57740-1. [DOI] [PubMed] [Google Scholar]
  • 10.Bergendal A, Naffah S, Nagy C, Bergqvist A, Sjöblom P, Hillensjö T. Outcome of IVF in patients with endometriosis in comparison with tubal-factor infertility. J Assist Reprod Genet. 1998;15:530–534. doi: 10.1023/A:1022526002421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wardle PG, Mitchell JD, McLaughlin EA, Ray BD, McDermot A, Hull MG. Endometriosis and ovulatory disorder: Reduced fertilisation in vitro compared with tubal and unexplained infertility. Lancet. 1985;2:236–239. doi: 10.1016/s0140-6736(85)90289-2. [DOI] [PubMed] [Google Scholar]
  • 12.Huang H-Y, Lee C-L, Lai Y-M, Chang M-Y, Chang S-Y, Soong Y-K. The outcome of in vitro fertilization and embryo transfer therapy in women with endometriosis failing to conceive after laparoscopic conservative surgery. J Am Assoc Gynecol Lapar. 1997;4:299–303. doi: 10.1016/s1074-3804(05)80219-1. [DOI] [PubMed] [Google Scholar]
  • 13.Hull MGR, Williams JAC, Ray B, McLaughlin EA, Akande VA, Ford WCL. The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis associated or unexplained infertility: A controlled comparison with tubal infertility and use of donor spermatozoa. Hum Reprod. 1998;13:1825–1830. doi: 10.1093/humrep/13.7.1825. [DOI] [PubMed] [Google Scholar]
  • 14.Gutiérrez A, Oliveira N, Cano F, Ruiz A, Simón C, Remohi J, Pellicer A. In vitro fertilization in infertile patients with endometriosis. Assist Reprod Rev. 1994;4:162–171. [Google Scholar]
  • 15.Tanbo T, Omland A, Dale PO, Åbyholm T. In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis. Acta Obstet Gynecol Scand. 1995;74:539–543. doi: 10.3109/00016349509024386. [DOI] [PubMed] [Google Scholar]
  • 16.Fridström M, Garoff L, Sjöblom P, Hillensjö T. Human chorionic gonadotropin patterns in early pregnancy after assisted reproduction. Acta Obstet Gynecol Scand. 1995;74:534–538. doi: 10.3109/00016349509024385. [DOI] [PubMed] [Google Scholar]
  • 17.Minguez Y, Rubio C, Bernal A, Gaitan P, Remohi J, Simón C, Pellicer A. The impact of endometriosis in couples undergoing intra-cytoplasmic sperm injection because of male infertility. Hum Reprod. 1997;12:2282–2285. doi: 10.1093/humrep/12.10.2282. [DOI] [PubMed] [Google Scholar]
  • 18.Doody MC, Gibbons WE, Buttram VC., Jr Linear regression analysis of ultrasound follicular growth series: Evidence for an abnormality of follicular growth in endometriosis patients. Fertil Steril. 1988;49:47–51. doi: 10.1016/s0015-0282(16)59646-0. [DOI] [PubMed] [Google Scholar]
  • 19.Carlberg M, Nejaty J, Fröysa B, Guan Y, Söder O, Bergqvist A. Elevated expression of tumour necrosis factor ? in cultured granulosa cells from women with endometriosis. Hum Reprod. 2000;15:1250–1255. doi: 10.1093/humrep/15.6.1250. [DOI] [PubMed] [Google Scholar]
  • 20.Buyalos RP, Watson JM, Martinez-Maza O. Detection of interleukin-6 in human follicular fluid. Fertil Steril. 1992;57:1230–1234. [PubMed] [Google Scholar]
  • 21.Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simón C. The follicular and endocrine environment in women with endometriosis: Local and systemic cytokine production. Fertil Steril. 1998;70:425–431. doi: 10.1016/s0015-0282(98)00204-0. [DOI] [PubMed] [Google Scholar]
  • 22.Naz RK, Zhu X, Menge AC. Expression of tumor necrosis factor-alpha and its receptors type I and II in human oocytes. Mol Reprod Dev. 1997;47:127–133. doi: 10.1002/(SICI)1098-2795(199706)47:2<127::AID-MRD1>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  • 23.Cohen PE, Pollard JW. Cytokines and growth factors in reproduction. In: Bronson RA, Alexander NJ, Anderson D, Ware Branch P, Kutteh WH, editors. Reproductive Immunology. England, Blackwell: Oxford; 1996. pp. 52–102. [Google Scholar]
  • 24.Rier SE, Yeaman GR. Immune aspects of endometriosis: Relevance of the uterine mucosal immune system. Sem Reprod Endocrinol. 1997;15:209–220. doi: 10.1055/s-2008-1068750. [DOI] [PubMed] [Google Scholar]
  • 25.Koninckx PR, Kennedy SH, Barlow DH. Pathogenesis of endometriosis: The role of peritoneal fluid. Gynecol Obstet Invest. 1999;47(Suppl.):23–33. doi: 10.1159/000052856. [DOI] [PubMed] [Google Scholar]
  • 26.Ueki M, Tsurunaga T, Ushiroyama T, Ueda M. Macrophage activation factors and cytokines in peritoneal fluid from patients with endometriosis. Asia Oceania J Obstet Gynaecol. 1994;20:427–431. doi: 10.1111/j.1447-0756.1994.tb00492.x. [DOI] [PubMed] [Google Scholar]
  • 27.Bergqvist A, Brunkwall J, Ploman F. Concentrations of prostaglandin F2? in follicular fluid from women with endometriosis. Hum Reprod. 1997;12:1789–1793. doi: 10.1093/humrep/12.8.1789. [DOI] [PubMed] [Google Scholar]
  • 28.Palmisano GP, Adamson GD, Lamb EJ. Can staging systems for endometriosis based on anatomic location and lesion type predict pregnancy rates? Int J Fertil Menopausal Stud. 1993;38:241–249. [PubMed] [Google Scholar]
  • 29.Pal L, Shifren JL, Isaacson KB, Chang Y, Leykin L, Toth TL. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer. J Assist Reprod Genet. 1998;15:27–31. doi: 10.1023/A:1022574221115. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES